Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$4,011,202
+$121,184 QoQ
Shares Held
15,794
-0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.54%
of 13F equity value
Holder Rank
#1,771
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Center for Financial Planning, Inc. holds $12,258,532 across 12 Drug Manufacturers - General names. JNJ ranks #2 (32.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
17,400 | $4,378,536 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
15,794 | $4,011,202 | |
| 3 | MRK |
Merck & Co., Inc.
|
11,433 | $1,469,140 | |
| 4 | LLY |
ELI LILLY & Co
|
995 | $1,193,432 | |
| 5 | AMGN |
Amgen Inc
|
1,349 | $488,499 | |
| 6 | PFE |
Pfizer Inc
|
13,544 | $326,139 | |
| 7 | NVO |
Novo Nordisk A S
|
3,079 | $147,607 | |
| 8 | AZN |
Astrazeneca PLC
|
528 | $100,119 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,011,202 | 15,794 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $3,890,018 | 15,914 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $3,313,062 | 16,009 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,911,650 | 15,703 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,245,730 | 14,702 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $2,439,506 | 14,710 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $2,111,885 | 14,603 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $2,441,109 | 15,063 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $2,243,702 | 15,351 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $2,443,402 | 15,446 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $2,397,338 | 15,295 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $2,380,950 | 15,287 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,504,483 | 15,131 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,332,595 | 15,049 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,599,581 | 14,716 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $2,364,962 | 14,477 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $2,550,641 | 14,369 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,501,246 | 14,113 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $2,338,697 | 13,671 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,192,039 | 13,573 | Shares | Sole | 2021-11-17 | |
| 2021-06-30 | $1,995,660 | 12,114 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $2,067,687 | 12,581 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,955,131 | 12,423 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,849,536 | 12,423 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,737,202 | 12,353 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $1,641,747 | 12,520 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||